{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":null,"value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"24","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":null,"per_page":12,"people":[{"id":447303,"version":1,"owner_type":"Person","owner_id":7295,"payload":{"bio":"\u003cp\u003eCorey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\u003c/p\u003e\n\u003cp\u003eHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate\u0026nbsp;fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ\u0026rsquo;s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ\u0026rsquo;s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ\u0026rsquo;s Fifth Circuit representative advising on national criminal policies.\u003c/p\u003e\n\u003cp\u003eIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\u003c/p\u003e\n\u003cp\u003eHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\u003c/p\u003e\n\u003cp\u003eDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director\u0026rsquo;s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury.\u003c/p\u003e","slug":"corey-amundson","email":"camundson@kslaw.com","phone":null,"matters":["\u003cp\u003eSupervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People\u0026rsquo;s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney\u0026rsquo;s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.\u003c/p\u003e","\u003cp\u003eSupervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.\u003c/p\u003e","\u003cp\u003eCo-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.\u003c/p\u003e","\u003cp\u003eSupervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ\u0026rsquo;s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG\u0026rsquo;s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":5,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":6,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":7,"source":"smartTags"},{"id":1114,"guid":"1114.smart_tags","index":8,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":10,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":11,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":12,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":13,"source":"smartTags"},{"id":1409,"guid":"1409.smart_tags","index":14,"source":"smartTags"}],"is_active":true,"last_name":"Amundson","nick_name":"Corey","clerkships":[{"name":"Law Clerk, The Honorable Sarah Evans Barker, U.S. District Court for the Southern District of Indiana","years_held":"1997 - 1999"}],"first_name":"Corey","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1997-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Exceptional Service Award","detail":"U.S. Department of Justice, 2024 and 2022"},{"title":"Honorary Special Agent Award","detail":"Internal Revenue Service, Criminal Investigations, 2018"},{"title":"Commendation","detail":"U.S. Drug Enforcement Agency, 2018"},{"title":"Commendations","detail":"Federal Bureau of Investigation, 2017, 2008, 2004"},{"title":"Commendation","detail":"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016"},{"title":"Director’s Award for Superior Performance by a Litigative Group","detail":"U.S. Department of Justice, 2013"},{"title":"Commendations","detail":"Inspector General, U.S. Department of Homeland Security, 2013 and 2010"},{"title":"Commendation","detail":"U.S. Attorney General, 2013"},{"title":"Extraordinary Efforts Award","detail":"Federal Bureau of Investigation, 2012"},{"title":"Integrity Award","detail":"Inspector General, U.S. Department of Health and Human Services, 2008"},{"title":"Exceptional Service in the Public Interest Award","detail":"Federal Bureau of Investigation, 2008"}],"linked_in_url":"https://www.linkedin.com/in/corey-r-amundson-6632ab18b/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCorey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\u003c/p\u003e\n\u003cp\u003eHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate\u0026nbsp;fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ\u0026rsquo;s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ\u0026rsquo;s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ\u0026rsquo;s Fifth Circuit representative advising on national criminal policies.\u003c/p\u003e\n\u003cp\u003eIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\u003c/p\u003e\n\u003cp\u003eHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\u003c/p\u003e\n\u003cp\u003eDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director\u0026rsquo;s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury.\u003c/p\u003e","matters":["\u003cp\u003eSupervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People\u0026rsquo;s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney\u0026rsquo;s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.\u003c/p\u003e","\u003cp\u003eSupervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.\u003c/p\u003e","\u003cp\u003eCo-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.\u003c/p\u003e","\u003cp\u003eSupervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ\u0026rsquo;s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG\u0026rsquo;s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.\u003c/p\u003e"],"recognitions":[{"title":"Exceptional Service Award","detail":"U.S. Department of Justice, 2024 and 2022"},{"title":"Honorary Special Agent Award","detail":"Internal Revenue Service, Criminal Investigations, 2018"},{"title":"Commendation","detail":"U.S. Drug Enforcement Agency, 2018"},{"title":"Commendations","detail":"Federal Bureau of Investigation, 2017, 2008, 2004"},{"title":"Commendation","detail":"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016"},{"title":"Director’s Award for Superior Performance by a Litigative Group","detail":"U.S. Department of Justice, 2013"},{"title":"Commendations","detail":"Inspector General, U.S. Department of Homeland Security, 2013 and 2010"},{"title":"Commendation","detail":"U.S. Attorney General, 2013"},{"title":"Extraordinary Efforts Award","detail":"Federal Bureau of Investigation, 2012"},{"title":"Integrity Award","detail":"Inspector General, U.S. Department of Health and Human Services, 2008"},{"title":"Exceptional Service in the Public Interest Award","detail":"Federal Bureau of Investigation, 2008"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13326}]},"capability_group_id":2},"created_at":"2026-04-04T09:08:37.000Z","updated_at":"2026-04-04T09:08:37.000Z","searchable_text":"Amundson{{ FIELD }}{:title=\u0026gt;\"Exceptional Service Award\", :detail=\u0026gt;\"U.S. Department of Justice, 2024 and 2022\"}{{ FIELD }}{:title=\u0026gt;\"Honorary Special Agent Award\", :detail=\u0026gt;\"Internal Revenue Service, Criminal Investigations, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"U.S. Drug Enforcement Agency, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Commendations\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2017, 2008, 2004\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Director’s Award for Superior Performance by a Litigative Group\", :detail=\u0026gt;\"U.S. Department of Justice, 2013\"}{{ FIELD }}{:title=\u0026gt;\"Commendations\", :detail=\u0026gt;\"Inspector General, U.S. Department of Homeland Security, 2013 and 2010\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"U.S. Attorney General, 2013\"}{{ FIELD }}{:title=\u0026gt;\"Extraordinary Efforts Award\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2012\"}{{ FIELD }}{:title=\u0026gt;\"Integrity Award\", :detail=\u0026gt;\"Inspector General, U.S. Department of Health and Human Services, 2008\"}{{ FIELD }}{:title=\u0026gt;\"Exceptional Service in the Public Interest Award\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2008\"}{{ FIELD }}Supervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.{{ FIELD }}Lead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People’s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.{{ FIELD }}Co-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney’s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.{{ FIELD }}Co-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.{{ FIELD }}Lead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.{{ FIELD }}Supervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.{{ FIELD }}Co-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.{{ FIELD }}Supervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ’s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG’s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.{{ FIELD }}Lead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.{{ FIELD }}Lead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.{{ FIELD }}Lead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.{{ FIELD }}Corey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\nHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities. \nCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney’s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.  \nIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ’s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ’s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney’s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ’s Fifth Circuit representative advising on national criminal policies.\nIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\nHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\nDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director’s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury. Partner Exceptional Service Award U.S. Department of Justice, 2024 and 2022 Honorary Special Agent Award Internal Revenue Service, Criminal Investigations, 2018 Commendation U.S. Drug Enforcement Agency, 2018 Commendations Federal Bureau of Investigation, 2017, 2008, 2004 Commendation Inspector General, Tax Administration, U.S. Department of the Treasury, 2016 Director’s Award for Superior Performance by a Litigative Group U.S. Department of Justice, 2013 Commendations Inspector General, U.S. Department of Homeland Security, 2013 and 2010 Commendation U.S. Attorney General, 2013 Extraordinary Efforts Award Federal Bureau of Investigation, 2012 Integrity Award Inspector General, U.S. Department of Health and Human Services, 2008 Exceptional Service in the Public Interest Award Federal Bureau of Investigation, 2008 Indiana University Indiana University School of Law Emory University Emory University School of Law U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Middle District of Louisiana U.S. District Court for the Southern District of Indiana Supreme Court of Louisiana American Bar Association Law Clerk, The Honorable Sarah Evans Barker, U.S. District Court for the Southern District of Indiana Supervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America. Lead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People’s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty. Co-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney’s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time. Co-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery. Lead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution. Supervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others. Co-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties. Supervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ’s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG’s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims. Lead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria. Lead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business. Lead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.","searchable_name":"Corey R. Amundson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":446196,"version":1,"owner_type":"Person","owner_id":6879,"payload":{"bio":"\u003cp\u003eRecognized by \u003cem\u003eChambers USA\u003c/em\u003e for Antitrust \u0026ndash; New York for more than a decade, and perennially listed in \u003cem\u003eGlobal Competition Review\u003c/em\u003e\u0026rsquo;s Who\u0026rsquo;s Who Legal of Competition Lawyers in New York and other similar publications, clients turn to Olivier for antitrust counseling when it matters most for their company. Olivier focuses primarily on antitrust counseling for \u0026ldquo;bet the company\u0026rdquo; transactional matters, as well as high-stakes antitrust litigation and government investigations.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eOlivier has extensive experience representing merging parties, or merger opponents, in transactions raising significant antitrust scrutiny before U.S. Antitrust agencies as well as foreign competition authorities.\u0026nbsp; Olivier has successfully obtained merger clearances in highly contested transactions, and successfully represented merger opponents in some of the most high-profile abandoned transactions and joint ventures.\u003c/p\u003e\n\u003cp\u003eOlivier often provides \u0026ldquo;one-stop-shop\u0026rdquo; counseling on international antitrust questions requiring a bespoke analysis globally. Olivier's practice also includes civil and criminal antitrust enforcement matters and antitrust audit counseling.\u003c/p\u003e\n\u003cp\u003eOlivier's work has covered a broad range of industries, including financial institutions, telecommunications, video distribution, satellite radio, recorded music and music publishing, fixed satellites, oil and gas, paper and forestry products, pharmaceuticals and medical devices, healthcare, food products and food service, bread, spirits, beer, vitamins, textiles, chemicals, fertilizers, sports goods, airlines, automotive and automotive parts, semiconductors, media buying, and advertising.\u003c/p\u003e","slug":"olivier-antoine","email":"oantoine@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eRepresentative M\u0026amp;A and Joint Venture Experience\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent DIRECTV in many transactions including the proposed acquisition of the DISH video distribution business from EchoStar, and Standard General\u0026rsquo;s abandoned acquisition of TEGNA, as well as Disney, Fox, and Warner Brother Discovery\u0026rsquo;s abandoned \u0026ldquo;Venu\u0026rdquo; streaming Joint Venture, and the proposed Nexstar/TEGNA transaction.\u003c/p\u003e","\u003cp\u003eAT\u0026amp;T Inc. in many transactions including its recent $5.75 billion acquisition of Lumen Technologies\u0026rsquo; Mass Markets Fiber-to-the-home business, and its recent acquisition of wireless spectrum licenses from EchoStar for $23 billion, the $43 billion spin off Warner Media to Discovery, the $7.8 billion sale of an interest in DIRECTV to TPG, the $1.175 billion sale of the Crunchyroll business to Sony, the $108.7 billion acquisition of Time Warner Inc., its $67 billion acquisition of DIRECTV, its $1.19 billion acquisition of Leap Wireless, its $944 million acquisition of Centennial Communications, and its attempted $39 billion acquisition of T-Mobile USA Inc.\u003c/p\u003e","\u003cp\u003eSiemens AG in many transactions including the $1.3 billion sale of its Healthcare IT business to Cerner, the sale of its microbiology business to Danaher, and its global collaboration with Varian Medical Systems, and Siemens Healthineers in its $1.1 billion acquisition of Corindus Vascular Robotics.\u003c/p\u003e","\u003cp\u003eA third-party foodservice divestiture acquirer in connection with U.S. Foods\u0026rsquo;s $1.8 billion acquisition of Service Group of America, Inc. and several other matters including Sysco\u0026rsquo;s proposed acquisition of U.S. Foods.\u003c/p\u003e","\u003cp\u003eUnited Technologies in connection with its $30 billion acquisition of Rockwell Collins, and its $15.5 billion acquisition of Goodrich.\u003c/p\u003e","\u003cp\u003eTransCanada in its $13 billion acquisition of Columbia Pipeline Group.\u003c/p\u003e","\u003cp\u003eAlcoa in its $2.85 billion acquisition of Firth Rixson.\u003c/p\u003e","\u003cp\u003eGoldman Sachs \u0026amp; Co. in its spinoff of the REDI business.\u003c/p\u003e","\u003cp\u003eFlowers Foods in its $355 million acquisition of the Hostess bread assets.\u003c/p\u003e","\u003cp\u003eDuPont in the $4.9 billion sale of DuPont Paint and Coating business to the Carlyle Group.\u003c/p\u003e","\u003cp\u003eVeolia in the $1.9 billion sale of its waste assets to Highstar Capital.\u003c/p\u003e","\u003cp\u003eReed Elsevier PLC in its $4.1 billion acquisition of ChoicePoint.\u003c/p\u003e","\u003cp\u003eSirius Satellite Radio in its $13 billion merger with XM Satellite Radio.\u003c/p\u003e","\u003cp\u003eTravelport in its $1.4 billion acquisition of Worldspan.\u003c/p\u003e","\u003cp\u003eSmithfield Foods in its $810 million acquisition of Premium Standard Foods, and its $367 million acquisition of Farmland Foods.\u003c/p\u003e","\u003cp\u003ePanAmSat in its $3.2 billion sale to Intelsat.\u003c/p\u003e","\u003cp\u003eAdidas AG in its $3.8 billion acquisition of Reebok.\u003c/p\u003e","\u003cp\u003eVNU in the attempted $7 billion acquisition of IMS Health.\u003c/p\u003e","\u003cp\u003eCelanese before the European Commission in its $492 million acquisition of Acetex. (Phase II investigation)\u003c/p\u003e","\u003cp\u003eGrey Global in its $1.7 billion sale to WPP.\u003c/p\u003e","\u003cp\u003eCSL in its $925 million acquisition of the Aventis Behring plasma business.\u003c/p\u003e","\u003cp\u003eVivendi Universal in its $8.1 billion sale of the Seagram Spirits and Wine business to Diageo and Pernod Ricard.\u003c/p\u003e","\u003cp\u003eTotal before the European Commission in its \u0026euro;50 billion acquisition of Elf. (Phase II investigation)\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRepresentative Litigation Experience\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eDIRECTV LLC v. Nexstar Media Group, Inc. et al\u003c/em\u003e, No 1:2023cv02221 \u0026ndash; Represent DIRECTV in antitrust litigation against Nexstar Media Group, Mission Broadcasting and White Knight Broadcast.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eFuboTV Inc. et al v. The Walt Disney Company et al,\u0026nbsp;\u003c/em\u003e1:24-cv-01363-MMG (S.D.N.Y) \u0026ndash; Represented DIRECTV in connection with the proposed \u0026ldquo;Venu\u0026rdquo; streaming joint venture by Disney, Fox and Warner Brothers Discovery. The parties eventually abandoned the joint venture following opposition from non-parties EchoStar and DIRECTV.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eState of New York et al. v. Deutsche Telekom et al,\u0026nbsp;\u003c/em\u003eNo 1:19-cv-05434 (S.D.N.Y) \u0026ndash; Represented AT\u0026amp;T Inc. in connection with the New York Attorney General et al. challenge of T-Mobile USA\u0026rsquo;s proposed $56 billion acquisition of Sprint.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eE.I. du Pont de Nemours and Co. v. Kolon Industries, Inc\u003c/em\u003e., No. 3.09cv58 (E.D.VA) \u0026ndash; Represented E.I. du Pont de Nemours and Company in trade secret infringement litigation against Kolon Industries, Inc., and related monopolization counterclaim (ED Va). DuPont won a $919.9 million verdict, and the antitrust counterclaim was dismissed with prejudice.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Air Cargo Antitrust Litigation\u003c/em\u003e, MDL-1715 (E.D.N.Y.) \u0026ndash; Represented a European airline in defending class action claims that air cargo rates were fixed.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Digital Music Antitrust Litigation\u003c/em\u003e, No. 06 MD 1780 (S.D.N.Y) \u0026ndash; Represented Warner Music Group in connection with DOJ and NYAG investigations regarding the pricing of digital music and in class action claims filed against music companies alleging collusion in digital music pricing.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Methyl-Methacrylate Antitrust Litigation\u003c/em\u003e, MDL-1768 (E.D. Pa.) \u0026ndash; Represented Lucite Inc. in class actions alleging a conspiracy to fix prices of methyl-methacrylate (MMA) and polymethyl-methacrylate (PMMA).\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Publication Paper Antitrust Litigation\u0026nbsp;\u003c/em\u003e(MDL No. 1631, D. Conn.) \u0026ndash; Represented a major pulp and paper producer in a nationwide antitrust action alleging an unlawful conspiracy to fix the price of publication paper.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3225}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":4,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":5,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":8,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":9,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":10,"source":"smartTags"},{"id":1220,"guid":"1220.smart_tags","index":11,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":12,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":13,"source":"smartTags"},{"id":762,"guid":"762.smart_tags","index":14,"source":"smartTags"},{"id":1141,"guid":"1141.smart_tags","index":15,"source":"smartTags"},{"id":1,"guid":"1.capabilities","index":16,"source":"capabilities"}],"is_active":true,"last_name":"Antoine","nick_name":"Olivier","clerkships":[],"first_name":"Olivier","title_rank":9999,"updated_by":202,"law_schools":[{"id":722,"meta":{"degree":"LL.M.","honors":"cum laude","is_law_school":"1","graduation_date":"1999-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"N.","name_suffix":"","recognitions":[{"title":"Global Competition Review: GCR 100","detail":"2013-2025"},{"title":"Chambers USA: Antitrust – New York","detail":"2013 - 2024"}],"linked_in_url":"https://www.linkedin.com/in/oantoine/","seodescription":"Olivier is a partner","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRecognized by \u003cem\u003eChambers USA\u003c/em\u003e for Antitrust \u0026ndash; New York for more than a decade, and perennially listed in \u003cem\u003eGlobal Competition Review\u003c/em\u003e\u0026rsquo;s Who\u0026rsquo;s Who Legal of Competition Lawyers in New York and other similar publications, clients turn to Olivier for antitrust counseling when it matters most for their company. Olivier focuses primarily on antitrust counseling for \u0026ldquo;bet the company\u0026rdquo; transactional matters, as well as high-stakes antitrust litigation and government investigations.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eOlivier has extensive experience representing merging parties, or merger opponents, in transactions raising significant antitrust scrutiny before U.S. Antitrust agencies as well as foreign competition authorities.\u0026nbsp; Olivier has successfully obtained merger clearances in highly contested transactions, and successfully represented merger opponents in some of the most high-profile abandoned transactions and joint ventures.\u003c/p\u003e\n\u003cp\u003eOlivier often provides \u0026ldquo;one-stop-shop\u0026rdquo; counseling on international antitrust questions requiring a bespoke analysis globally. Olivier's practice also includes civil and criminal antitrust enforcement matters and antitrust audit counseling.\u003c/p\u003e\n\u003cp\u003eOlivier's work has covered a broad range of industries, including financial institutions, telecommunications, video distribution, satellite radio, recorded music and music publishing, fixed satellites, oil and gas, paper and forestry products, pharmaceuticals and medical devices, healthcare, food products and food service, bread, spirits, beer, vitamins, textiles, chemicals, fertilizers, sports goods, airlines, automotive and automotive parts, semiconductors, media buying, and advertising.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eRepresentative M\u0026amp;A and Joint Venture Experience\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent DIRECTV in many transactions including the proposed acquisition of the DISH video distribution business from EchoStar, and Standard General\u0026rsquo;s abandoned acquisition of TEGNA, as well as Disney, Fox, and Warner Brother Discovery\u0026rsquo;s abandoned \u0026ldquo;Venu\u0026rdquo; streaming Joint Venture, and the proposed Nexstar/TEGNA transaction.\u003c/p\u003e","\u003cp\u003eAT\u0026amp;T Inc. in many transactions including its recent $5.75 billion acquisition of Lumen Technologies\u0026rsquo; Mass Markets Fiber-to-the-home business, and its recent acquisition of wireless spectrum licenses from EchoStar for $23 billion, the $43 billion spin off Warner Media to Discovery, the $7.8 billion sale of an interest in DIRECTV to TPG, the $1.175 billion sale of the Crunchyroll business to Sony, the $108.7 billion acquisition of Time Warner Inc., its $67 billion acquisition of DIRECTV, its $1.19 billion acquisition of Leap Wireless, its $944 million acquisition of Centennial Communications, and its attempted $39 billion acquisition of T-Mobile USA Inc.\u003c/p\u003e","\u003cp\u003eSiemens AG in many transactions including the $1.3 billion sale of its Healthcare IT business to Cerner, the sale of its microbiology business to Danaher, and its global collaboration with Varian Medical Systems, and Siemens Healthineers in its $1.1 billion acquisition of Corindus Vascular Robotics.\u003c/p\u003e","\u003cp\u003eA third-party foodservice divestiture acquirer in connection with U.S. Foods\u0026rsquo;s $1.8 billion acquisition of Service Group of America, Inc. and several other matters including Sysco\u0026rsquo;s proposed acquisition of U.S. Foods.\u003c/p\u003e","\u003cp\u003eUnited Technologies in connection with its $30 billion acquisition of Rockwell Collins, and its $15.5 billion acquisition of Goodrich.\u003c/p\u003e","\u003cp\u003eTransCanada in its $13 billion acquisition of Columbia Pipeline Group.\u003c/p\u003e","\u003cp\u003eAlcoa in its $2.85 billion acquisition of Firth Rixson.\u003c/p\u003e","\u003cp\u003eGoldman Sachs \u0026amp; Co. in its spinoff of the REDI business.\u003c/p\u003e","\u003cp\u003eFlowers Foods in its $355 million acquisition of the Hostess bread assets.\u003c/p\u003e","\u003cp\u003eDuPont in the $4.9 billion sale of DuPont Paint and Coating business to the Carlyle Group.\u003c/p\u003e","\u003cp\u003eVeolia in the $1.9 billion sale of its waste assets to Highstar Capital.\u003c/p\u003e","\u003cp\u003eReed Elsevier PLC in its $4.1 billion acquisition of ChoicePoint.\u003c/p\u003e","\u003cp\u003eSirius Satellite Radio in its $13 billion merger with XM Satellite Radio.\u003c/p\u003e","\u003cp\u003eTravelport in its $1.4 billion acquisition of Worldspan.\u003c/p\u003e","\u003cp\u003eSmithfield Foods in its $810 million acquisition of Premium Standard Foods, and its $367 million acquisition of Farmland Foods.\u003c/p\u003e","\u003cp\u003ePanAmSat in its $3.2 billion sale to Intelsat.\u003c/p\u003e","\u003cp\u003eAdidas AG in its $3.8 billion acquisition of Reebok.\u003c/p\u003e","\u003cp\u003eVNU in the attempted $7 billion acquisition of IMS Health.\u003c/p\u003e","\u003cp\u003eCelanese before the European Commission in its $492 million acquisition of Acetex. (Phase II investigation)\u003c/p\u003e","\u003cp\u003eGrey Global in its $1.7 billion sale to WPP.\u003c/p\u003e","\u003cp\u003eCSL in its $925 million acquisition of the Aventis Behring plasma business.\u003c/p\u003e","\u003cp\u003eVivendi Universal in its $8.1 billion sale of the Seagram Spirits and Wine business to Diageo and Pernod Ricard.\u003c/p\u003e","\u003cp\u003eTotal before the European Commission in its \u0026euro;50 billion acquisition of Elf. (Phase II investigation)\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRepresentative Litigation Experience\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eDIRECTV LLC v. Nexstar Media Group, Inc. et al\u003c/em\u003e, No 1:2023cv02221 \u0026ndash; Represent DIRECTV in antitrust litigation against Nexstar Media Group, Mission Broadcasting and White Knight Broadcast.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eFuboTV Inc. et al v. The Walt Disney Company et al,\u0026nbsp;\u003c/em\u003e1:24-cv-01363-MMG (S.D.N.Y) \u0026ndash; Represented DIRECTV in connection with the proposed \u0026ldquo;Venu\u0026rdquo; streaming joint venture by Disney, Fox and Warner Brothers Discovery. The parties eventually abandoned the joint venture following opposition from non-parties EchoStar and DIRECTV.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eState of New York et al. v. Deutsche Telekom et al,\u0026nbsp;\u003c/em\u003eNo 1:19-cv-05434 (S.D.N.Y) \u0026ndash; Represented AT\u0026amp;T Inc. in connection with the New York Attorney General et al. challenge of T-Mobile USA\u0026rsquo;s proposed $56 billion acquisition of Sprint.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eE.I. du Pont de Nemours and Co. v. Kolon Industries, Inc\u003c/em\u003e., No. 3.09cv58 (E.D.VA) \u0026ndash; Represented E.I. du Pont de Nemours and Company in trade secret infringement litigation against Kolon Industries, Inc., and related monopolization counterclaim (ED Va). DuPont won a $919.9 million verdict, and the antitrust counterclaim was dismissed with prejudice.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Air Cargo Antitrust Litigation\u003c/em\u003e, MDL-1715 (E.D.N.Y.) \u0026ndash; Represented a European airline in defending class action claims that air cargo rates were fixed.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Digital Music Antitrust Litigation\u003c/em\u003e, No. 06 MD 1780 (S.D.N.Y) \u0026ndash; Represented Warner Music Group in connection with DOJ and NYAG investigations regarding the pricing of digital music and in class action claims filed against music companies alleging collusion in digital music pricing.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Methyl-Methacrylate Antitrust Litigation\u003c/em\u003e, MDL-1768 (E.D. Pa.) \u0026ndash; Represented Lucite Inc. in class actions alleging a conspiracy to fix prices of methyl-methacrylate (MMA) and polymethyl-methacrylate (PMMA).\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn re Publication Paper Antitrust Litigation\u0026nbsp;\u003c/em\u003e(MDL No. 1631, D. Conn.) \u0026ndash; Represented a major pulp and paper producer in a nationwide antitrust action alleging an unlawful conspiracy to fix the price of publication paper.\u003c/p\u003e"],"recognitions":[{"title":"Global Competition Review: GCR 100","detail":"2013-2025"},{"title":"Chambers USA: Antitrust – New York","detail":"2013 - 2024"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12282}]},"capability_group_id":3},"created_at":"2026-02-27T14:37:17.000Z","updated_at":"2026-02-27T14:37:17.000Z","searchable_text":"Antoine{{ FIELD }}{:title=\u0026gt;\"Global Competition Review: GCR 100\", :detail=\u0026gt;\"2013-2025\"}{{ FIELD }}{:title=\u0026gt;\"Chambers USA: Antitrust – New York\", :detail=\u0026gt;\"2013 - 2024\"}{{ FIELD }}Representative M\u0026amp;A and Joint Venture Experience\nRepresent DIRECTV in many transactions including the proposed acquisition of the DISH video distribution business from EchoStar, and Standard General’s abandoned acquisition of TEGNA, as well as Disney, Fox, and Warner Brother Discovery’s abandoned “Venu” streaming Joint Venture, and the proposed Nexstar/TEGNA transaction.{{ FIELD }}AT\u0026amp;T Inc. in many transactions including its recent $5.75 billion acquisition of Lumen Technologies’ Mass Markets Fiber-to-the-home business, and its recent acquisition of wireless spectrum licenses from EchoStar for $23 billion, the $43 billion spin off Warner Media to Discovery, the $7.8 billion sale of an interest in DIRECTV to TPG, the $1.175 billion sale of the Crunchyroll business to Sony, the $108.7 billion acquisition of Time Warner Inc., its $67 billion acquisition of DIRECTV, its $1.19 billion acquisition of Leap Wireless, its $944 million acquisition of Centennial Communications, and its attempted $39 billion acquisition of T-Mobile USA Inc.{{ FIELD }}Siemens AG in many transactions including the $1.3 billion sale of its Healthcare IT business to Cerner, the sale of its microbiology business to Danaher, and its global collaboration with Varian Medical Systems, and Siemens Healthineers in its $1.1 billion acquisition of Corindus Vascular Robotics.{{ FIELD }}A third-party foodservice divestiture acquirer in connection with U.S. Foods’s $1.8 billion acquisition of Service Group of America, Inc. and several other matters including Sysco’s proposed acquisition of U.S. Foods.{{ FIELD }}United Technologies in connection with its $30 billion acquisition of Rockwell Collins, and its $15.5 billion acquisition of Goodrich.{{ FIELD }}TransCanada in its $13 billion acquisition of Columbia Pipeline Group.{{ FIELD }}Alcoa in its $2.85 billion acquisition of Firth Rixson.{{ FIELD }}Goldman Sachs \u0026amp; Co. in its spinoff of the REDI business.{{ FIELD }}Flowers Foods in its $355 million acquisition of the Hostess bread assets.{{ FIELD }}DuPont in the $4.9 billion sale of DuPont Paint and Coating business to the Carlyle Group.{{ FIELD }}Veolia in the $1.9 billion sale of its waste assets to Highstar Capital.{{ FIELD }}Reed Elsevier PLC in its $4.1 billion acquisition of ChoicePoint.{{ FIELD }}Sirius Satellite Radio in its $13 billion merger with XM Satellite Radio.{{ FIELD }}Travelport in its $1.4 billion acquisition of Worldspan.{{ FIELD }}Smithfield Foods in its $810 million acquisition of Premium Standard Foods, and its $367 million acquisition of Farmland Foods.{{ FIELD }}PanAmSat in its $3.2 billion sale to Intelsat.{{ FIELD }}Adidas AG in its $3.8 billion acquisition of Reebok.{{ FIELD }}VNU in the attempted $7 billion acquisition of IMS Health.{{ FIELD }}Celanese before the European Commission in its $492 million acquisition of Acetex. (Phase II investigation){{ FIELD }}Grey Global in its $1.7 billion sale to WPP.{{ FIELD }}CSL in its $925 million acquisition of the Aventis Behring plasma business.{{ FIELD }}Vivendi Universal in its $8.1 billion sale of the Seagram Spirits and Wine business to Diageo and Pernod Ricard.{{ FIELD }}Total before the European Commission in its €50 billion acquisition of Elf. (Phase II investigation){{ FIELD }}Representative Litigation Experience\nDIRECTV LLC v. Nexstar Media Group, Inc. et al, No 1:2023cv02221 – Represent DIRECTV in antitrust litigation against Nexstar Media Group, Mission Broadcasting and White Knight Broadcast.{{ FIELD }}FuboTV Inc. et al v. The Walt Disney Company et al, 1:24-cv-01363-MMG (S.D.N.Y) – Represented DIRECTV in connection with the proposed “Venu” streaming joint venture by Disney, Fox and Warner Brothers Discovery. The parties eventually abandoned the joint venture following opposition from non-parties EchoStar and DIRECTV.{{ FIELD }}State of New York et al. v. Deutsche Telekom et al, No 1:19-cv-05434 (S.D.N.Y) – Represented AT\u0026amp;T Inc. in connection with the New York Attorney General et al. challenge of T-Mobile USA’s proposed $56 billion acquisition of Sprint.{{ FIELD }}E.I. du Pont de Nemours and Co. v. Kolon Industries, Inc., No. 3.09cv58 (E.D.VA) – Represented E.I. du Pont de Nemours and Company in trade secret infringement litigation against Kolon Industries, Inc., and related monopolization counterclaim (ED Va). DuPont won a $919.9 million verdict, and the antitrust counterclaim was dismissed with prejudice.{{ FIELD }}In re Air Cargo Antitrust Litigation, MDL-1715 (E.D.N.Y.) – Represented a European airline in defending class action claims that air cargo rates were fixed.{{ FIELD }}In re Digital Music Antitrust Litigation, No. 06 MD 1780 (S.D.N.Y) – Represented Warner Music Group in connection with DOJ and NYAG investigations regarding the pricing of digital music and in class action claims filed against music companies alleging collusion in digital music pricing.{{ FIELD }}In re Methyl-Methacrylate Antitrust Litigation, MDL-1768 (E.D. Pa.) – Represented Lucite Inc. in class actions alleging a conspiracy to fix prices of methyl-methacrylate (MMA) and polymethyl-methacrylate (PMMA).{{ FIELD }}In re Publication Paper Antitrust Litigation (MDL No. 1631, D. Conn.) – Represented a major pulp and paper producer in a nationwide antitrust action alleging an unlawful conspiracy to fix the price of publication paper.{{ FIELD }}Recognized by Chambers USA for Antitrust – New York for more than a decade, and perennially listed in Global Competition Review’s Who’s Who Legal of Competition Lawyers in New York and other similar publications, clients turn to Olivier for antitrust counseling when it matters most for their company. Olivier focuses primarily on antitrust counseling for “bet the company” transactional matters, as well as high-stakes antitrust litigation and government investigations.\nOlivier has extensive experience representing merging parties, or merger opponents, in transactions raising significant antitrust scrutiny before U.S. Antitrust agencies as well as foreign competition authorities.  Olivier has successfully obtained merger clearances in highly contested transactions, and successfully represented merger opponents in some of the most high-profile abandoned transactions and joint ventures.\nOlivier often provides “one-stop-shop” counseling on international antitrust questions requiring a bespoke analysis globally. Olivier's practice also includes civil and criminal antitrust enforcement matters and antitrust audit counseling.\nOlivier's work has covered a broad range of industries, including financial institutions, telecommunications, video distribution, satellite radio, recorded music and music publishing, fixed satellites, oil and gas, paper and forestry products, pharmaceuticals and medical devices, healthcare, food products and food service, bread, spirits, beer, vitamins, textiles, chemicals, fertilizers, sports goods, airlines, automotive and automotive parts, semiconductors, media buying, and advertising. Olivier Antoine lawyer Partner Global Competition Review: GCR 100 2013-2025 Chambers USA: Antitrust – New York 2013 - 2024 University of Paris, Pantheon Sorbonne  Fordham University Fordham University School of Law University of Paris, Pantheon Sorbonne  New York New York State Bar Association, Chair of the International Antitrust and Competition Law Committee American Bar Association, Member of the International Antitrust Law Committee Steering Group Representative M\u0026amp;A and Joint Venture Experience\nRepresent DIRECTV in many transactions including the proposed acquisition of the DISH video distribution business from EchoStar, and Standard General’s abandoned acquisition of TEGNA, as well as Disney, Fox, and Warner Brother Discovery’s abandoned “Venu” streaming Joint Venture, and the proposed Nexstar/TEGNA transaction. AT\u0026amp;T Inc. in many transactions including its recent $5.75 billion acquisition of Lumen Technologies’ Mass Markets Fiber-to-the-home business, and its recent acquisition of wireless spectrum licenses from EchoStar for $23 billion, the $43 billion spin off Warner Media to Discovery, the $7.8 billion sale of an interest in DIRECTV to TPG, the $1.175 billion sale of the Crunchyroll business to Sony, the $108.7 billion acquisition of Time Warner Inc., its $67 billion acquisition of DIRECTV, its $1.19 billion acquisition of Leap Wireless, its $944 million acquisition of Centennial Communications, and its attempted $39 billion acquisition of T-Mobile USA Inc. Siemens AG in many transactions including the $1.3 billion sale of its Healthcare IT business to Cerner, the sale of its microbiology business to Danaher, and its global collaboration with Varian Medical Systems, and Siemens Healthineers in its $1.1 billion acquisition of Corindus Vascular Robotics. A third-party foodservice divestiture acquirer in connection with U.S. Foods’s $1.8 billion acquisition of Service Group of America, Inc. and several other matters including Sysco’s proposed acquisition of U.S. Foods. United Technologies in connection with its $30 billion acquisition of Rockwell Collins, and its $15.5 billion acquisition of Goodrich. TransCanada in its $13 billion acquisition of Columbia Pipeline Group. Alcoa in its $2.85 billion acquisition of Firth Rixson. Goldman Sachs \u0026amp; Co. in its spinoff of the REDI business. Flowers Foods in its $355 million acquisition of the Hostess bread assets. DuPont in the $4.9 billion sale of DuPont Paint and Coating business to the Carlyle Group. Veolia in the $1.9 billion sale of its waste assets to Highstar Capital. Reed Elsevier PLC in its $4.1 billion acquisition of ChoicePoint. Sirius Satellite Radio in its $13 billion merger with XM Satellite Radio. Travelport in its $1.4 billion acquisition of Worldspan. Smithfield Foods in its $810 million acquisition of Premium Standard Foods, and its $367 million acquisition of Farmland Foods. PanAmSat in its $3.2 billion sale to Intelsat. Adidas AG in its $3.8 billion acquisition of Reebok. VNU in the attempted $7 billion acquisition of IMS Health. Celanese before the European Commission in its $492 million acquisition of Acetex. (Phase II investigation) Grey Global in its $1.7 billion sale to WPP. CSL in its $925 million acquisition of the Aventis Behring plasma business. Vivendi Universal in its $8.1 billion sale of the Seagram Spirits and Wine business to Diageo and Pernod Ricard. Total before the European Commission in its €50 billion acquisition of Elf. (Phase II investigation) Representative Litigation Experience\nDIRECTV LLC v. Nexstar Media Group, Inc. et al, No 1:2023cv02221 – Represent DIRECTV in antitrust litigation against Nexstar Media Group, Mission Broadcasting and White Knight Broadcast. FuboTV Inc. et al v. The Walt Disney Company et al, 1:24-cv-01363-MMG (S.D.N.Y) – Represented DIRECTV in connection with the proposed “Venu” streaming joint venture by Disney, Fox and Warner Brothers Discovery. The parties eventually abandoned the joint venture following opposition from non-parties EchoStar and DIRECTV. State of New York et al. v. Deutsche Telekom et al, No 1:19-cv-05434 (S.D.N.Y) – Represented AT\u0026amp;T Inc. in connection with the New York Attorney General et al. challenge of T-Mobile USA’s proposed $56 billion acquisition of Sprint. E.I. du Pont de Nemours and Co. v. Kolon Industries, Inc., No. 3.09cv58 (E.D.VA) – Represented E.I. du Pont de Nemours and Company in trade secret infringement litigation against Kolon Industries, Inc., and related monopolization counterclaim (ED Va). DuPont won a $919.9 million verdict, and the antitrust counterclaim was dismissed with prejudice. In re Air Cargo Antitrust Litigation, MDL-1715 (E.D.N.Y.) – Represented a European airline in defending class action claims that air cargo rates were fixed. In re Digital Music Antitrust Litigation, No. 06 MD 1780 (S.D.N.Y) – Represented Warner Music Group in connection with DOJ and NYAG investigations regarding the pricing of digital music and in class action claims filed against music companies alleging collusion in digital music pricing. In re Methyl-Methacrylate Antitrust Litigation, MDL-1768 (E.D. Pa.) – Represented Lucite Inc. in class actions alleging a conspiracy to fix prices of methyl-methacrylate (MMA) and polymethyl-methacrylate (PMMA). In re Publication Paper Antitrust Litigation (MDL No. 1631, D. Conn.) – Represented a major pulp and paper producer in a nationwide antitrust action alleging an unlawful conspiracy to fix the price of publication paper.","searchable_name":"Olivier N. Antoine","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436428,"version":1,"owner_type":"Person","owner_id":3554,"payload":{"bio":"\u003cp\u003eGardner Armsby is a partner in King \u0026amp; Spalding\u0026rsquo;s Healthcare practice and advises healthcare industry clients on corporate transactions and regulatory compliance matters. He represents for-profit and non-profit healthcare companies, as well as lenders, private equity firms, and other healthcare investors. With a unique combination of corporate and regulatory expertise, Gardner assists clients in structuring, negotiating, and executing transactions in the highly regulated healthcare industry, including mergers and acquisitions, reorganizations, joint ventures, financings, management arrangements, affiliations, and other complex transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGardner also counsels clients on healthcare regulatory and compliance matters, including corporate practice of medicine restrictions, fraud and abuse laws, HIPAA, licensing and certificate of need requirements, and 501(c)(3) tax-exemption issues.\u003c/p\u003e\n\u003cp\u003eGardner has worked with a broad spectrum of healthcare businesses, including health systems, hospitals, surgery centers, nursing homes, physician practices, home health and hospice agencies, laboratories, pharmacies, medical supply companies, and electronic health records companies, among others.\u003c/p\u003e\n\u003cp\u003eGardner graduated first in his class from Georgia State University College of Law. He received his undergraduate degree in Economics from the University of Georgia. Prior to attending law school, Gardner worked as CFO and Corporate Compliance Officer for a 501(c)(3) non-profit provider of vocational training services for adults with disabilities.\u003c/p\u003e","slug":"john-armsby","email":"garmsby@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented nonprofit and for-profit health system clients in acquisitions and divestitures of dozens of acute-care and specialty hospitals, including a $1 billion acquisition of a three-hospital nonprofit system, a $950 million acquisition of three hospitals from a publicly traded system, and a $750 million sale of three acute-care hospitals and an LTACH by a publicly traded system.\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems in joint venture transactions with private equity sponsors and other investor-owned entities involving ambulatory surgery centers, rehabilitation hospitals, behavioral health facilities, urgent care centers, and other specialty facilities.\u003c/p\u003e","\u003cp\u003eRepresented multi-specialty physician group in $2 billion sale to physician practice management subsidiary of publicly traded company.\u003c/p\u003e","\u003cp\u003eRepresented committee of physician and management investors in private equity-backed physician practice management company in $900+ million recapitalization transaction.\u003c/p\u003e","\u003cp\u003eRepresented private equity sponsors and portfolio companies in platform and roll-up acquisitions of physician practices and related ancillary healthcare businesses.\u003c/p\u003e","\u003cp\u003eRepresented physician practices of various specialties (including anesthesiology, emergency medicine, oncology, orthopedics, primary care, radiology, and multi-specialty groups) in sales to private equity sponsors, health systems, and other buyers.\u003c/p\u003e","\u003cp\u003eRepresented foreign investor in platform acquisition of nurse staffing business and subsequent roll-up transactions.\u003c/p\u003e","\u003cp\u003eRepresented academic medical center system in overhaul of its corporate governance structure.\u003c/p\u003e","\u003cp\u003eRepresented hospital owned by state-government entity in reorganization transaction involving transfer of hospital operations and lease of assets to newly formed nonprofit entity.\u003c/p\u003e","\u003cp\u003eRepresented multiple buyers and sellers in transactions involving skilled nursing facilities, personal care homes, and other senior living facilities.\u003c/p\u003e","\u003cp\u003eRepresented closely held hospice business in carve-out sale of multiple hospice agencies to private equity-backed national hospice chain.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":4,"source":"smartTags"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Armsby","nick_name":"Gardner","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":202,"law_schools":[{"id":761,"meta":{"degree":"J.D.","honors":"summa cum laude","is_law_school":"1","graduation_date":"2015-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Gardner","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eGardner Armsby is a partner in King \u0026amp; Spalding\u0026rsquo;s Healthcare practice and advises healthcare industry clients on corporate transactions and regulatory compliance matters. He represents for-profit and non-profit healthcare companies, as well as lenders, private equity firms, and other healthcare investors. With a unique combination of corporate and regulatory expertise, Gardner assists clients in structuring, negotiating, and executing transactions in the highly regulated healthcare industry, including mergers and acquisitions, reorganizations, joint ventures, financings, management arrangements, affiliations, and other complex transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGardner also counsels clients on healthcare regulatory and compliance matters, including corporate practice of medicine restrictions, fraud and abuse laws, HIPAA, licensing and certificate of need requirements, and 501(c)(3) tax-exemption issues.\u003c/p\u003e\n\u003cp\u003eGardner has worked with a broad spectrum of healthcare businesses, including health systems, hospitals, surgery centers, nursing homes, physician practices, home health and hospice agencies, laboratories, pharmacies, medical supply companies, and electronic health records companies, among others.\u003c/p\u003e\n\u003cp\u003eGardner graduated first in his class from Georgia State University College of Law. He received his undergraduate degree in Economics from the University of Georgia. Prior to attending law school, Gardner worked as CFO and Corporate Compliance Officer for a 501(c)(3) non-profit provider of vocational training services for adults with disabilities.\u003c/p\u003e","matters":["\u003cp\u003eRepresented nonprofit and for-profit health system clients in acquisitions and divestitures of dozens of acute-care and specialty hospitals, including a $1 billion acquisition of a three-hospital nonprofit system, a $950 million acquisition of three hospitals from a publicly traded system, and a $750 million sale of three acute-care hospitals and an LTACH by a publicly traded system.\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems in joint venture transactions with private equity sponsors and other investor-owned entities involving ambulatory surgery centers, rehabilitation hospitals, behavioral health facilities, urgent care centers, and other specialty facilities.\u003c/p\u003e","\u003cp\u003eRepresented multi-specialty physician group in $2 billion sale to physician practice management subsidiary of publicly traded company.\u003c/p\u003e","\u003cp\u003eRepresented committee of physician and management investors in private equity-backed physician practice management company in $900+ million recapitalization transaction.\u003c/p\u003e","\u003cp\u003eRepresented private equity sponsors and portfolio companies in platform and roll-up acquisitions of physician practices and related ancillary healthcare businesses.\u003c/p\u003e","\u003cp\u003eRepresented physician practices of various specialties (including anesthesiology, emergency medicine, oncology, orthopedics, primary care, radiology, and multi-specialty groups) in sales to private equity sponsors, health systems, and other buyers.\u003c/p\u003e","\u003cp\u003eRepresented foreign investor in platform acquisition of nurse staffing business and subsequent roll-up transactions.\u003c/p\u003e","\u003cp\u003eRepresented academic medical center system in overhaul of its corporate governance structure.\u003c/p\u003e","\u003cp\u003eRepresented hospital owned by state-government entity in reorganization transaction involving transfer of hospital operations and lease of assets to newly formed nonprofit entity.\u003c/p\u003e","\u003cp\u003eRepresented multiple buyers and sellers in transactions involving skilled nursing facilities, personal care homes, and other senior living facilities.\u003c/p\u003e","\u003cp\u003eRepresented closely held hospice business in carve-out sale of multiple hospice agencies to private equity-backed national hospice chain.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11781}]},"capability_group_id":2},"created_at":"2025-09-02T04:53:09.000Z","updated_at":"2025-09-02T04:53:09.000Z","searchable_text":"Armsby{{ FIELD }}Represented nonprofit and for-profit health system clients in acquisitions and divestitures of dozens of acute-care and specialty hospitals, including a $1 billion acquisition of a three-hospital nonprofit system, a $950 million acquisition of three hospitals from a publicly traded system, and a $750 million sale of three acute-care hospitals and an LTACH by a publicly traded system.{{ FIELD }}Represented multiple health systems in joint venture transactions with private equity sponsors and other investor-owned entities involving ambulatory surgery centers, rehabilitation hospitals, behavioral health facilities, urgent care centers, and other specialty facilities.{{ FIELD }}Represented multi-specialty physician group in $2 billion sale to physician practice management subsidiary of publicly traded company.{{ FIELD }}Represented committee of physician and management investors in private equity-backed physician practice management company in $900+ million recapitalization transaction.{{ FIELD }}Represented private equity sponsors and portfolio companies in platform and roll-up acquisitions of physician practices and related ancillary healthcare businesses.{{ FIELD }}Represented physician practices of various specialties (including anesthesiology, emergency medicine, oncology, orthopedics, primary care, radiology, and multi-specialty groups) in sales to private equity sponsors, health systems, and other buyers.{{ FIELD }}Represented foreign investor in platform acquisition of nurse staffing business and subsequent roll-up transactions.{{ FIELD }}Represented academic medical center system in overhaul of its corporate governance structure.{{ FIELD }}Represented hospital owned by state-government entity in reorganization transaction involving transfer of hospital operations and lease of assets to newly formed nonprofit entity.{{ FIELD }}Represented multiple buyers and sellers in transactions involving skilled nursing facilities, personal care homes, and other senior living facilities.{{ FIELD }}Represented closely held hospice business in carve-out sale of multiple hospice agencies to private equity-backed national hospice chain.{{ FIELD }}Gardner Armsby is a partner in King \u0026amp; Spalding’s Healthcare practice and advises healthcare industry clients on corporate transactions and regulatory compliance matters. He represents for-profit and non-profit healthcare companies, as well as lenders, private equity firms, and other healthcare investors. With a unique combination of corporate and regulatory expertise, Gardner assists clients in structuring, negotiating, and executing transactions in the highly regulated healthcare industry, including mergers and acquisitions, reorganizations, joint ventures, financings, management arrangements, affiliations, and other complex transactions.\nGardner also counsels clients on healthcare regulatory and compliance matters, including corporate practice of medicine restrictions, fraud and abuse laws, HIPAA, licensing and certificate of need requirements, and 501(c)(3) tax-exemption issues.\nGardner has worked with a broad spectrum of healthcare businesses, including health systems, hospitals, surgery centers, nursing homes, physician practices, home health and hospice agencies, laboratories, pharmacies, medical supply companies, and electronic health records companies, among others.\nGardner graduated first in his class from Georgia State University College of Law. He received his undergraduate degree in Economics from the University of Georgia. Prior to attending law school, Gardner worked as CFO and Corporate Compliance Officer for a 501(c)(3) non-profit provider of vocational training services for adults with disabilities. Partner University of Georgia University of Georgia School of Law Georgia State University Georgia State University College of Law Georgia Georgia Academy of Healthcare Attorneys American Health Lawyers Association Represented nonprofit and for-profit health system clients in acquisitions and divestitures of dozens of acute-care and specialty hospitals, including a $1 billion acquisition of a three-hospital nonprofit system, a $950 million acquisition of three hospitals from a publicly traded system, and a $750 million sale of three acute-care hospitals and an LTACH by a publicly traded system. Represented multiple health systems in joint venture transactions with private equity sponsors and other investor-owned entities involving ambulatory surgery centers, rehabilitation hospitals, behavioral health facilities, urgent care centers, and other specialty facilities. Represented multi-specialty physician group in $2 billion sale to physician practice management subsidiary of publicly traded company. Represented committee of physician and management investors in private equity-backed physician practice management company in $900+ million recapitalization transaction. Represented private equity sponsors and portfolio companies in platform and roll-up acquisitions of physician practices and related ancillary healthcare businesses. Represented physician practices of various specialties (including anesthesiology, emergency medicine, oncology, orthopedics, primary care, radiology, and multi-specialty groups) in sales to private equity sponsors, health systems, and other buyers. Represented foreign investor in platform acquisition of nurse staffing business and subsequent roll-up transactions. Represented academic medical center system in overhaul of its corporate governance structure. Represented hospital owned by state-government entity in reorganization transaction involving transfer of hospital operations and lease of assets to newly formed nonprofit entity. Represented multiple buyers and sellers in transactions involving skilled nursing facilities, personal care homes, and other senior living facilities. Represented closely held hospice business in carve-out sale of multiple hospice agencies to private equity-backed national hospice chain.","searchable_name":"John Gardner Armsby (Gardner)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427219,"version":1,"owner_type":"Person","owner_id":6490,"payload":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"adam-baker","email":"abaker@kslaw.com","phone":null,"matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":9,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Baker","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":32,"law_schools":[{"id":245,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/adam-baker-4a471038/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10412}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:19.000Z","updated_at":"2025-05-26T04:59:19.000Z","searchable_text":"Baker{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.{{ FIELD }}Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.{{ FIELD }}Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Adam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. \nPreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.  He also partnered with the DOJ’s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.   \nPrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees. \nAdam is active within the LGBTQ+ community. He helped found Boston Colleges’ first gay-straight alliance and served on his prior firm’s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School’s national alumni board and formerly served as a Corp member for Teach For America.   Partner Boston College Boston College Law School Boston College Boston College Law School Fordham University Fordham University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC. Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal. Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC. Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.","searchable_name":"Adam Baker","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":445539,"version":1,"owner_type":"Person","owner_id":6785,"payload":{"bio":"\u003cp\u003eDana Berkowitz represents healthcare providers in\u0026nbsp;a variety of high-stakes matters,\u0026nbsp;including reimbursement disputes, regulatory proceedings,\u0026nbsp;and commercial litigation and arbitration.\u0026nbsp; She also provides strategic advice to healthcare and life sciences startups and handles bet-the-company litigation on their behalf. \u0026nbsp;Dana has deep expertise in ERISA and behavioral healthcare. \u0026nbsp;\u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;describes her as \u0026ldquo;the full package\u0026rdquo; and \u0026ldquo;a gifted litigator and strategist\u0026rdquo; who is \u0026ldquo;knowledgeable and solutions-based.\u0026rdquo;\u0026nbsp; \u003cem\u003eLegal500\u003c/em\u003e\u0026nbsp;calls Dana \u0026ldquo;a superlative advocate and tactician.\u0026rdquo;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDana has a\u0026nbsp;long track record of achieving favorable outcomes for healthcare providers in a wide variety of payor disputes.\u0026nbsp; Her practice focuses on managed care litigation and arbitration.\u0026nbsp; Dana also helps providers navigate audits, rate disputes, recoupment demands, and other high-risk aspects of their payor relationships. Dana leverages her ERISA expertise to help her clients take advantage of opportunities, such as by using the Parity Act to improve reimbursement for mental health services.\u0026nbsp; Dana also advises providers on best practices, often in anticipation of sale.\u003c/p\u003e\n\u003cp\u003eDana has achieved success in several bet-the-company litigations and appeals for providers and other business clients.\u0026nbsp; For example, in 2019, she secured a complete defense verdict for a behavioral healthcare provider in a $195 million false advertising case.\u0026nbsp; In 2020, she successfully defended another provider in a four-week administrative trial against the State of California.\u0026nbsp; And in 2022, Dana led a large theft of trade secrets case to a favorable resolution for her biotech startup client.\u0026nbsp; Dana has also briefed and argued\u0026nbsp;high-profile appeals in federal and state courts across the nation.\u003c/p\u003e\n\u003cp\u003eSince 2022,\u0026nbsp;\u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;has recognized Dana as one of the top ERISA litigators in the nation.\u0026nbsp; \u003cem\u003eLegal500\u003c/em\u003e says that she is \u0026ldquo;unmatched in her ability to quickly ingest, organize, and master an enormous amount of factual information and synthesize it into a winning narrative.\u0026rdquo;\u0026nbsp; Dana has also been listed as a leading lawyer under 40 in \u003cem\u003eBenchmark Litigation\u003c/em\u003e and \u003cem\u003eNew York Law Journal\u003c/em\u003e.\u0026nbsp;\u003c/p\u003e","slug":"dana-berkowitz","email":"dberkowitz@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eParties Confidential.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eLead counsel to behavioral health company in rate dispute with major payor. Resolved after service of draft complaint for $30 million more than prior offer.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eHammell v. Pilot Products, Inc. Defined Benefit Pension Plan\u003c/em\u003e.\u003c/strong\u003e\u0026nbsp;Lead trial counsel for plaintiff in ERISA pension dispute. Won more than 90 percent of relief sought including over $1M in attorneys\u0026rsquo; fees.\u003c/p\u003e","\u003cp\u003eLead trial counsel to American biotech startup in nine-figure federal trade secrets litigation and international arbitration relating to next-generation COVID-19 vaccine. Matter resolved on favorable terms.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGrasshopper House LLC v. Clean \u0026amp; Sober Media LLC.\u003c/em\u003e\u003c/strong\u003e\u003cem\u003e\u0026nbsp;\u003c/em\u003eFirst-chaired bench trial on equitable relief after adverse jury verdict in Lanham Act case against well-known treatment facility, where plaintiff sought $195M. Court found unclean hands and awarded $0 to plaintiff.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eParties Confidential.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eResolved dispute on behalf of hospital against independent physician organization on eve of trial for double amount of claimed loss.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eIn re Creative Care.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eFirst-chaired four-week administrative trial against California in license revocation action. Secured complete defense victory for substance abuse treatment facility client.\u003c/p\u003e","\u003cp\u003eLead trial counsel in franchise arbitration against international coffeehouse chain. Awarded full amount of claimed loss.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBechard v. Brody.\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;Successfully briefed and argued California appeal of order denying motion to compel arbitration in dispute involving Michael Avenatti and Republican fundraiser Elliott Brody.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3251}]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":502,"guid":"502.smart_tags","index":5,"source":"smartTags"},{"id":740,"guid":"740.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Berkowitz","nick_name":"Dana","clerkships":[],"first_name":"Dana","title_rank":9999,"updated_by":202,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"She is a superlative advocate and tactician.\"","detail":"Legal 500, 2025"},{"title":"\"She's the full package: smart, good on her feet, dogged and fierce in all the right ways.\"","detail":"Chambers USA, 2025"},{"title":"Ranked in \"ERISA Litigation: Mainly Plaintiffs (Nationwide)\"","detail":"Chambers USA, 2022-25"},{"title":"Future Star","detail":"Benchmark Litigation, 2023"},{"title":"40 and Under Hot List","detail":"Benchmark Litigation, 2021-2022, 2024"},{"title":"Rising Star","detail":"New York Law Journal, 2018"}],"linked_in_url":null,"seodescription":"Dana is a lawyer at King \u0026 Spalding's New York Office. Read more about her.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDana Berkowitz represents healthcare providers in\u0026nbsp;a variety of high-stakes matters,\u0026nbsp;including reimbursement disputes, regulatory proceedings,\u0026nbsp;and commercial litigation and arbitration.\u0026nbsp; She also provides strategic advice to healthcare and life sciences startups and handles bet-the-company litigation on their behalf. \u0026nbsp;Dana has deep expertise in ERISA and behavioral healthcare. \u0026nbsp;\u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;describes her as \u0026ldquo;the full package\u0026rdquo; and \u0026ldquo;a gifted litigator and strategist\u0026rdquo; who is \u0026ldquo;knowledgeable and solutions-based.\u0026rdquo;\u0026nbsp; \u003cem\u003eLegal500\u003c/em\u003e\u0026nbsp;calls Dana \u0026ldquo;a superlative advocate and tactician.\u0026rdquo;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDana has a\u0026nbsp;long track record of achieving favorable outcomes for healthcare providers in a wide variety of payor disputes.\u0026nbsp; Her practice focuses on managed care litigation and arbitration.\u0026nbsp; Dana also helps providers navigate audits, rate disputes, recoupment demands, and other high-risk aspects of their payor relationships. Dana leverages her ERISA expertise to help her clients take advantage of opportunities, such as by using the Parity Act to improve reimbursement for mental health services.\u0026nbsp; Dana also advises providers on best practices, often in anticipation of sale.\u003c/p\u003e\n\u003cp\u003eDana has achieved success in several bet-the-company litigations and appeals for providers and other business clients.\u0026nbsp; For example, in 2019, she secured a complete defense verdict for a behavioral healthcare provider in a $195 million false advertising case.\u0026nbsp; In 2020, she successfully defended another provider in a four-week administrative trial against the State of California.\u0026nbsp; And in 2022, Dana led a large theft of trade secrets case to a favorable resolution for her biotech startup client.\u0026nbsp; Dana has also briefed and argued\u0026nbsp;high-profile appeals in federal and state courts across the nation.\u003c/p\u003e\n\u003cp\u003eSince 2022,\u0026nbsp;\u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;has recognized Dana as one of the top ERISA litigators in the nation.\u0026nbsp; \u003cem\u003eLegal500\u003c/em\u003e says that she is \u0026ldquo;unmatched in her ability to quickly ingest, organize, and master an enormous amount of factual information and synthesize it into a winning narrative.\u0026rdquo;\u0026nbsp; Dana has also been listed as a leading lawyer under 40 in \u003cem\u003eBenchmark Litigation\u003c/em\u003e and \u003cem\u003eNew York Law Journal\u003c/em\u003e.\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eParties Confidential.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eLead counsel to behavioral health company in rate dispute with major payor. Resolved after service of draft complaint for $30 million more than prior offer.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eHammell v. Pilot Products, Inc. Defined Benefit Pension Plan\u003c/em\u003e.\u003c/strong\u003e\u0026nbsp;Lead trial counsel for plaintiff in ERISA pension dispute. Won more than 90 percent of relief sought including over $1M in attorneys\u0026rsquo; fees.\u003c/p\u003e","\u003cp\u003eLead trial counsel to American biotech startup in nine-figure federal trade secrets litigation and international arbitration relating to next-generation COVID-19 vaccine. Matter resolved on favorable terms.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGrasshopper House LLC v. Clean \u0026amp; Sober Media LLC.\u003c/em\u003e\u003c/strong\u003e\u003cem\u003e\u0026nbsp;\u003c/em\u003eFirst-chaired bench trial on equitable relief after adverse jury verdict in Lanham Act case against well-known treatment facility, where plaintiff sought $195M. Court found unclean hands and awarded $0 to plaintiff.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eParties Confidential.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eResolved dispute on behalf of hospital against independent physician organization on eve of trial for double amount of claimed loss.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eIn re Creative Care.\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eFirst-chaired four-week administrative trial against California in license revocation action. Secured complete defense victory for substance abuse treatment facility client.\u003c/p\u003e","\u003cp\u003eLead trial counsel in franchise arbitration against international coffeehouse chain. Awarded full amount of claimed loss.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBechard v. Brody.\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;Successfully briefed and argued California appeal of order denying motion to compel arbitration in dispute involving Michael Avenatti and Republican fundraiser Elliott Brody.\u003c/p\u003e"],"recognitions":[{"title":"\"She is a superlative advocate and tactician.\"","detail":"Legal 500, 2025"},{"title":"\"She's the full package: smart, good on her feet, dogged and fierce in all the right ways.\"","detail":"Chambers USA, 2025"},{"title":"Ranked in \"ERISA Litigation: Mainly Plaintiffs (Nationwide)\"","detail":"Chambers USA, 2022-25"},{"title":"Future Star","detail":"Benchmark Litigation, 2023"},{"title":"40 and Under Hot List","detail":"Benchmark Litigation, 2021-2022, 2024"},{"title":"Rising Star","detail":"New York Law Journal, 2018"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11963}]},"capability_group_id":2},"created_at":"2026-02-03T16:24:39.000Z","updated_at":"2026-02-03T16:24:39.000Z","searchable_text":"Berkowitz{{ FIELD }}{:title=\u0026gt;\"\\\"She is a superlative advocate and tactician.\\\"\", :detail=\u0026gt;\"Legal 500, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"She's the full package: smart, good on her feet, dogged and fierce in all the right ways.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked in \\\"ERISA Litigation: Mainly Plaintiffs (Nationwide)\\\"\", :detail=\u0026gt;\"Chambers USA, 2022-25\"}{{ FIELD }}{:title=\u0026gt;\"Future Star\", :detail=\u0026gt;\"Benchmark Litigation, 2023\"}{{ FIELD }}{:title=\u0026gt;\"40 and Under Hot List\", :detail=\u0026gt;\"Benchmark Litigation, 2021-2022, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star\", :detail=\u0026gt;\"New York Law Journal, 2018\"}{{ FIELD }}Parties Confidential. Lead counsel to behavioral health company in rate dispute with major payor. Resolved after service of draft complaint for $30 million more than prior offer.{{ FIELD }}Hammell v. Pilot Products, Inc. Defined Benefit Pension Plan. Lead trial counsel for plaintiff in ERISA pension dispute. Won more than 90 percent of relief sought including over $1M in attorneys’ fees.{{ FIELD }}Lead trial counsel to American biotech startup in nine-figure federal trade secrets litigation and international arbitration relating to next-generation COVID-19 vaccine. Matter resolved on favorable terms.{{ FIELD }}Grasshopper House LLC v. Clean \u0026amp; Sober Media LLC. First-chaired bench trial on equitable relief after adverse jury verdict in Lanham Act case against well-known treatment facility, where plaintiff sought $195M. Court found unclean hands and awarded $0 to plaintiff.{{ FIELD }}Parties Confidential. Resolved dispute on behalf of hospital against independent physician organization on eve of trial for double amount of claimed loss.{{ FIELD }}In re Creative Care. First-chaired four-week administrative trial against California in license revocation action. Secured complete defense victory for substance abuse treatment facility client.{{ FIELD }}Lead trial counsel in franchise arbitration against international coffeehouse chain. Awarded full amount of claimed loss.{{ FIELD }}Bechard v. Brody. Successfully briefed and argued California appeal of order denying motion to compel arbitration in dispute involving Michael Avenatti and Republican fundraiser Elliott Brody.{{ FIELD }}Dana Berkowitz represents healthcare providers in a variety of high-stakes matters, including reimbursement disputes, regulatory proceedings, and commercial litigation and arbitration.  She also provides strategic advice to healthcare and life sciences startups and handles bet-the-company litigation on their behalf.  Dana has deep expertise in ERISA and behavioral healthcare.  Chambers USA describes her as “the full package” and “a gifted litigator and strategist” who is “knowledgeable and solutions-based.”  Legal500 calls Dana “a superlative advocate and tactician.”\nDana has a long track record of achieving favorable outcomes for healthcare providers in a wide variety of payor disputes.  Her practice focuses on managed care litigation and arbitration.  Dana also helps providers navigate audits, rate disputes, recoupment demands, and other high-risk aspects of their payor relationships. Dana leverages her ERISA expertise to help her clients take advantage of opportunities, such as by using the Parity Act to improve reimbursement for mental health services.  Dana also advises providers on best practices, often in anticipation of sale.\nDana has achieved success in several bet-the-company litigations and appeals for providers and other business clients.  For example, in 2019, she secured a complete defense verdict for a behavioral healthcare provider in a $195 million false advertising case.  In 2020, she successfully defended another provider in a four-week administrative trial against the State of California.  And in 2022, Dana led a large theft of trade secrets case to a favorable resolution for her biotech startup client.  Dana has also briefed and argued high-profile appeals in federal and state courts across the nation.\nSince 2022, Chambers USA has recognized Dana as one of the top ERISA litigators in the nation.  Legal500 says that she is “unmatched in her ability to quickly ingest, organize, and master an enormous amount of factual information and synthesize it into a winning narrative.”  Dana has also been listed as a leading lawyer under 40 in Benchmark Litigation and New York Law Journal.  Dana Berkowitz lawyer Partner \"She is a superlative advocate and tactician.\" Legal 500, 2025 \"She's the full package: smart, good on her feet, dogged and fierce in all the right ways.\" Chambers USA, 2025 Ranked in \"ERISA Litigation: Mainly Plaintiffs (Nationwide)\" Chambers USA, 2022-25 Future Star Benchmark Litigation, 2023 40 and Under Hot List Benchmark Litigation, 2021-2022, 2024 Rising Star New York Law Journal, 2018 Princeton University  Harvard University Harvard Law School U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Ninth Circuit Central District of California California New York American Bar Association, Employee Benefits Committee Parties Confidential. Lead counsel to behavioral health company in rate dispute with major payor. Resolved after service of draft complaint for $30 million more than prior offer. Hammell v. Pilot Products, Inc. Defined Benefit Pension Plan. Lead trial counsel for plaintiff in ERISA pension dispute. Won more than 90 percent of relief sought including over $1M in attorneys’ fees. Lead trial counsel to American biotech startup in nine-figure federal trade secrets litigation and international arbitration relating to next-generation COVID-19 vaccine. Matter resolved on favorable terms. Grasshopper House LLC v. Clean \u0026amp; Sober Media LLC. First-chaired bench trial on equitable relief after adverse jury verdict in Lanham Act case against well-known treatment facility, where plaintiff sought $195M. Court found unclean hands and awarded $0 to plaintiff. Parties Confidential. Resolved dispute on behalf of hospital against independent physician organization on eve of trial for double amount of claimed loss. In re Creative Care. First-chaired four-week administrative trial against California in license revocation action. Secured complete defense victory for substance abuse treatment facility client. Lead trial counsel in franchise arbitration against international coffeehouse chain. Awarded full amount of claimed loss. Bechard v. Brody. Successfully briefed and argued California appeal of order denying motion to compel arbitration in dispute involving Michael Avenatti and Republican fundraiser Elliott Brody.","searchable_name":"Dana Berkowitz","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426841,"version":1,"owner_type":"Person","owner_id":5738,"payload":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","slug":"craig-bessenger","email":"cbessenger@kslaw.com","phone":null,"matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":3,"source":"capabilities"},{"id":18,"guid":"18.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Bessenger","nick_name":"Craig","clerkships":[{"name":"Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California","years_held":"2010 - 2011"}],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":2158,"meta":{"degree":"J.D.","honors":"Magna Cum Laude","is_law_school":"1","graduation_date":"2006-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"H.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8096}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:19.000Z","updated_at":"2025-05-26T04:57:19.000Z","searchable_text":"Bessenger{{ FIELD }}Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.{{ FIELD }}Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation.{{ FIELD }}Represented publicly-traded healthcare company in numerous class actions.{{ FIELD }}Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.{{ FIELD }}Represented bank directors in civil enforcement actions brought by federal regulatory authorities.{{ FIELD }}Represented a medical device manufacturer in an investigation by state regulatory authorities.{{ FIELD }}Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.{{ FIELD }}Craig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations. Partner Brown University  University of California Hastings College of Law University of California Hastings College of Law U.S. District Court for the Central District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California District of Columbia Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case. Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal. Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal. Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation. Represented publicly-traded healthcare company in numerous class actions. Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations. Represented bank directors in civil enforcement actions brought by federal regulatory authorities. Represented a medical device manufacturer in an investigation by state regulatory authorities. Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.","searchable_name":"Craig H. Bessenger","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":427703,"version":1,"owner_type":"Person","owner_id":1673,"payload":{"bio":"\u003cp\u003eBrian Bohnenkamp specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. A partner in our FDA practice and a member of our Life Sciences group, Brian has extensive experience counseling manufacturers on fraud and abuse laws, industry codes of conduct, federal and state transparency laws and regulations, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith a master\u0026rsquo;s degree in healthcare administration, Brian provides counsel to companies on a variety of laws and regulations administered and enforced by FDA, OIG, DOJ, and CMS, as well as by state attorneys general, boards of pharmacy, departments of health, and similar administrative and enforcement authorities. He regularly assists manufacturers in designing and implementing comprehensive compliance programs, and conducts risk assessments, audits and other reviews of compliance programs and business activities/operations.\u003c/p\u003e\n\u003cp\u003eBrian is regarded as a national expert on life sciences transparency laws and regulations, including the federal Physician Payments Sunshine Act (aka Open Payments) and similar state laws. He provides counsel to the Ad Hoc Sunshine and State Law Compliance Group, a coalition of pharmaceutical, biotechnology and medical device manufacturers.\u003c/p\u003e","slug":"brian-bohnenkamp","email":"bbohnenkamp@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":25}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":5,"source":"smartTags"},{"id":122,"guid":"122.capabilities","index":6,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":7,"source":"smartTags"},{"id":1193,"guid":"1193.smart_tags","index":8,"source":"smartTags"}],"is_active":true,"last_name":"Bohnenkamp","nick_name":"Brian","clerkships":[],"first_name":"Brian","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"A.","name_suffix":"","recognitions":[{"title":"Up and Coming, Healthcare: Pharmaceutical /Medical Products Regulatory ","detail":"Chambers USA, District of Columbia (2020-2022)"},{"title":"\"Brian's knowledge and experience are invaluable.\" ","detail":"Chambers USA (2022) "},{"title":"Next Generation Partner","detail":"Legal 500"},{"title":"Up and Coming for Pharmaceutical/Medical Products Regulatory","detail":"Chambers"},{"title":"Rising Star ","detail":"Washington, D.C. Super Lawyers, 2017-2020"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBrian Bohnenkamp specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. A partner in our FDA practice and a member of our Life Sciences group, Brian has extensive experience counseling manufacturers on fraud and abuse laws, industry codes of conduct, federal and state transparency laws and regulations, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith a master\u0026rsquo;s degree in healthcare administration, Brian provides counsel to companies on a variety of laws and regulations administered and enforced by FDA, OIG, DOJ, and CMS, as well as by state attorneys general, boards of pharmacy, departments of health, and similar administrative and enforcement authorities. He regularly assists manufacturers in designing and implementing comprehensive compliance programs, and conducts risk assessments, audits and other reviews of compliance programs and business activities/operations.\u003c/p\u003e\n\u003cp\u003eBrian is regarded as a national expert on life sciences transparency laws and regulations, including the federal Physician Payments Sunshine Act (aka Open Payments) and similar state laws. He provides counsel to the Ad Hoc Sunshine and State Law Compliance Group, a coalition of pharmaceutical, biotechnology and medical device manufacturers.\u003c/p\u003e","recognitions":[{"title":"Up and Coming, Healthcare: Pharmaceutical /Medical Products Regulatory ","detail":"Chambers USA, District of Columbia (2020-2022)"},{"title":"\"Brian's knowledge and experience are invaluable.\" ","detail":"Chambers USA (2022) "},{"title":"Next Generation Partner","detail":"Legal 500"},{"title":"Up and Coming for Pharmaceutical/Medical Products Regulatory","detail":"Chambers"},{"title":"Rising Star ","detail":"Washington, D.C. Super Lawyers, 2017-2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":735}]},"capability_group_id":2},"created_at":"2025-05-26T05:03:56.000Z","updated_at":"2025-05-26T05:03:56.000Z","searchable_text":"Bohnenkamp{{ FIELD }}{:title=\u0026gt;\"Up and Coming, Healthcare: Pharmaceutical /Medical Products Regulatory \", :detail=\u0026gt;\"Chambers USA, District of Columbia (2020-2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Brian's knowledge and experience are invaluable.\\\" \", :detail=\u0026gt;\"Chambers USA (2022) \"}{{ FIELD }}{:title=\u0026gt;\"Next Generation Partner\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Up and Coming for Pharmaceutical/Medical Products Regulatory\", :detail=\u0026gt;\"Chambers\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star \", :detail=\u0026gt;\"Washington, D.C. Super Lawyers, 2017-2020\"}{{ FIELD }}Brian Bohnenkamp specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. A partner in our FDA practice and a member of our Life Sciences group, Brian has extensive experience counseling manufacturers on fraud and abuse laws, industry codes of conduct, federal and state transparency laws and regulations, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions.\nWith a master’s degree in healthcare administration, Brian provides counsel to companies on a variety of laws and regulations administered and enforced by FDA, OIG, DOJ, and CMS, as well as by state attorneys general, boards of pharmacy, departments of health, and similar administrative and enforcement authorities. He regularly assists manufacturers in designing and implementing comprehensive compliance programs, and conducts risk assessments, audits and other reviews of compliance programs and business activities/operations.\nBrian is regarded as a national expert on life sciences transparency laws and regulations, including the federal Physician Payments Sunshine Act (aka Open Payments) and similar state laws. He provides counsel to the Ad Hoc Sunshine and State Law Compliance Group, a coalition of pharmaceutical, biotechnology and medical device manufacturers. Brian A Bohnenkamp Partner Up and Coming, Healthcare: Pharmaceutical /Medical Products Regulatory  Chambers USA, District of Columbia (2020-2022) \"Brian's knowledge and experience are invaluable.\"  Chambers USA (2022)  Next Generation Partner Legal 500 Up and Coming for Pharmaceutical/Medical Products Regulatory Chambers Rising Star  Washington, D.C. Super Lawyers, 2017-2020 Indiana University Indiana University School of Law St. Louis University  St. Louis University  District of Columbia Illinois","searchable_name":"Brian A. Bohnenkamp","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442359,"version":1,"owner_type":"Person","owner_id":850,"payload":{"bio":"\u003cp\u003eJim Boswell is co-head of King \u0026amp; Spalding's national Healthcare Team. His practice is devoted to handling litigation and investigations on behalf of healthcare industry clients. Jim also assists clients with regulatory and compliance questions and in connection with the negotiation of managed care agreements. Jim has particular expertise in handling managed care litigation on behalf of healthcare provider clients. He has also served as counsel in false claims act lawsuits in California, Georgia, Mississippi, Nevada, New York and Texas.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced healthcare litigator, Jim regularly handles motion arguments, hearings, arbitrations and trials\u0026nbsp;regarding specialized healthcare issues. He joined King \u0026amp; Spalding in 1992 after clerking on the United States Court of Appeals for the Fifth Circuit and became a partner of the firm in 1999.\u003c/p\u003e\n\u003cp\u003eJim has been listed in\u0026nbsp;\u003cem\u003eChambers USA, Super Lawyers, Best Lawyers in America,\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eGeorgia Trend\u0026rsquo;s\u003c/em\u003e\u0026nbsp;Legal Elite. A member of the American Health Lawyers Association\u0026rsquo;s Board of Directors, he chaired their Healthcare Liability and Litigation Practice Group from 2009-2012. In 2008, Jim was recognized as one of 12 \u0026ldquo;Outstanding Healthcare Litigators\u0026rdquo; nationwide by\u0026nbsp;\u003cem\u003eNightingale\u0026rsquo;s Healthcare News.\u003c/em\u003e\u0026nbsp;He is a past Chair of the Health Law Section of the State Bar of Georgia. Jim is also a frequent speaker and presenter.\u003c/p\u003e","slug":"james-boswell","email":"jboswell@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":151}]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":3,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":4,"source":"capabilities"},{"id":740,"guid":"740.smart_tags","index":5,"source":"smartTags"},{"id":120,"guid":"120.capabilities","index":6,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":7,"source":"capabilities"},{"id":1187,"guid":"1187.smart_tags","index":8,"source":"smartTags"}],"is_active":true,"last_name":"Boswell","nick_name":"Jim","clerkships":[{"name":"Law Clerk, Hon. Rhesa H. Barksdale, U.S. Court of Appeals for the Fifth Circuit","years_held":"1991 - 1992"}],"first_name":"James","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"W.","name_suffix":"III","recognitions":[{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Georgia (2014-2015, 2019-2022)"},{"title":"\"He's incredibly knowledgeable and can explain extremely complex healthcare regulations to the court.\"","detail":"Chambers USA (2022)"}],"linked_in_url":"https://www.linkedin.com/in/jimboswell2/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJim Boswell is co-head of King \u0026amp; Spalding's national Healthcare Team. His practice is devoted to handling litigation and investigations on behalf of healthcare industry clients. Jim also assists clients with regulatory and compliance questions and in connection with the negotiation of managed care agreements. Jim has particular expertise in handling managed care litigation on behalf of healthcare provider clients. He has also served as counsel in false claims act lawsuits in California, Georgia, Mississippi, Nevada, New York and Texas.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced healthcare litigator, Jim regularly handles motion arguments, hearings, arbitrations and trials\u0026nbsp;regarding specialized healthcare issues. He joined King \u0026amp; Spalding in 1992 after clerking on the United States Court of Appeals for the Fifth Circuit and became a partner of the firm in 1999.\u003c/p\u003e\n\u003cp\u003eJim has been listed in\u0026nbsp;\u003cem\u003eChambers USA, Super Lawyers, Best Lawyers in America,\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eGeorgia Trend\u0026rsquo;s\u003c/em\u003e\u0026nbsp;Legal Elite. A member of the American Health Lawyers Association\u0026rsquo;s Board of Directors, he chaired their Healthcare Liability and Litigation Practice Group from 2009-2012. In 2008, Jim was recognized as one of 12 \u0026ldquo;Outstanding Healthcare Litigators\u0026rdquo; nationwide by\u0026nbsp;\u003cem\u003eNightingale\u0026rsquo;s Healthcare News.\u003c/em\u003e\u0026nbsp;He is a past Chair of the Health Law Section of the State Bar of Georgia. Jim is also a frequent speaker and presenter.\u003c/p\u003e","recognitions":[{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Georgia (2014-2015, 2019-2022)"},{"title":"\"He's incredibly knowledgeable and can explain extremely complex healthcare regulations to the court.\"","detail":"Chambers USA (2022)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5812}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:26.000Z","updated_at":"2025-11-05T05:03:26.000Z","searchable_text":"Boswell{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Georgia (2014-2015, 2019-2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"He's incredibly knowledgeable and can explain extremely complex healthcare regulations to the court.\\\"\", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}Jim Boswell is co-head of King \u0026amp; Spalding's national Healthcare Team. His practice is devoted to handling litigation and investigations on behalf of healthcare industry clients. Jim also assists clients with regulatory and compliance questions and in connection with the negotiation of managed care agreements. Jim has particular expertise in handling managed care litigation on behalf of healthcare provider clients. He has also served as counsel in false claims act lawsuits in California, Georgia, Mississippi, Nevada, New York and Texas.\nAn experienced healthcare litigator, Jim regularly handles motion arguments, hearings, arbitrations and trials regarding specialized healthcare issues. He joined King \u0026amp; Spalding in 1992 after clerking on the United States Court of Appeals for the Fifth Circuit and became a partner of the firm in 1999.\nJim has been listed in Chambers USA, Super Lawyers, Best Lawyers in America, and Georgia Trend’s Legal Elite. A member of the American Health Lawyers Association’s Board of Directors, he chaired their Healthcare Liability and Litigation Practice Group from 2009-2012. In 2008, Jim was recognized as one of 12 “Outstanding Healthcare Litigators” nationwide by Nightingale’s Healthcare News. He is a past Chair of the Health Law Section of the State Bar of Georgia. Jim is also a frequent speaker and presenter. James W Boswell Partner Top Ranked Lawyer, Healthcare Chambers USA, Georgia (2014-2015, 2019-2022) \"He's incredibly knowledgeable and can explain extremely complex healthcare regulations to the court.\" Chambers USA (2022) Millsaps College  Harvard University Harvard Law School Georgia State Bar of Georgia Law Clerk, Hon. Rhesa H. Barksdale, U.S. Court of Appeals for the Fifth Circuit","searchable_name":"James W. Boswell III (Jim)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":447104,"version":1,"owner_type":"Person","owner_id":6224,"payload":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","slug":"sara-brinkmann","email":"sbrinkmann@kslaw.com","phone":"+1 713 295 9930","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":8,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":9,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Brinkmann","nick_name":"Sara","clerkships":[{"name":"Law Clerk, Hon. David Hittner, Texas","years_held":"2009 - 2011"}],"first_name":"Sara","title_rank":9999,"updated_by":202,"law_schools":[{"id":2197,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}],"linked_in_url":"https://www.linkedin.com/in/sara-brinkmann-23b78335","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9607}]},"capability_group_id":2},"created_at":"2026-03-27T19:04:30.000Z","updated_at":"2026-03-27T19:04:30.000Z","searchable_text":"Brinkmann{{ FIELD }}{:title=\u0026gt;\"\\\"She is very calm, organized and responsive.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara has a very service-oriented ethos in how she practices.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Key Lawyer for Healthcare: Service Providers\", :detail=\u0026gt;\"Legal 500 USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is very good at keeping larger business outcomes in mind.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is intelligent and customer-focused, responsive and competent.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is an exceptional attorney who provided outstanding legal analysis.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Ranked Band 3 for Healthcare in Texas\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Women in the Law\", :detail=\u0026gt;\"Best Lawyers, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Top Rated Houston, TX Health Care Attorney\", :detail=\u0026gt;\"Super Lawyers, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Top Women Attorneys in Texas\", :detail=\u0026gt;\"2024\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"Best Lawyers - Texas, 2021 - 2023\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Texas, 2021-2023\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara offers notable experience in litigation and administrative proceedings.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“She is a really sharp lawyer.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case.{{ FIELD }}Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.{{ FIELD }}Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.{{ FIELD }}Advised hospital systems regarding affiliation agreements and other complex transactions.{{ FIELD }}Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.{{ FIELD }}Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.{{ FIELD }}Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.{{ FIELD }}Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.{{ FIELD }}Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.{{ FIELD }}Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.{{ FIELD }}Represented a Louisiana hospital system in federal antitrust case.{{ FIELD }}Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.{{ FIELD }}Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.{{ FIELD }}Sara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.  Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.  Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans. \nAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.  \nIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.  \nThrough Chambers USA, her clients have said: \n     \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\n     \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \n     \"Sara Brinkmann is a fantastic lawyer.\"\nSara is regularly recognized by publications like Chambers, Best Lawyers in America, and Super Lawyers. She is the past Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics. Partner \"She is very calm, organized and responsive.\" Chambers USA, 2025 \"Sara has a very service-oriented ethos in how she practices.\" Chambers USA, 2025 Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation Chambers USA, 2025 Ranked as a Key Lawyer for Healthcare: Service Providers Legal 500 USA, 2025 \"Sara is very good at keeping larger business outcomes in mind.\" Chambers USA 2024 \"Sara is intelligent and customer-focused, responsive and competent.\" Chambers USA 2024 \"Sara is an exceptional attorney who provided outstanding legal analysis.\" Chambers USA 2024 Ranked Band 3 for Healthcare in Texas Chambers USA 2024 Women in the Law Best Lawyers, 2022 Top Rated Houston, TX Health Care Attorney Super Lawyers, 2023-2024 Top Women Attorneys in Texas 2024 Best Lawyers in America Best Lawyers - Texas, 2021 - 2023 Top Ranked Lawyer, Healthcare Chambers USA, Texas, 2021-2023 “Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.” Chambers USA 2022 “Sara offers notable experience in litigation and administrative proceedings.” Chambers USA 2022 “Sara Brinkmann possesses significant experience and knowledge on complex issues.” Chambers USA 2022 Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.” Chambers USA 2022 “She is a really sharp lawyer.” Chambers USA 2022 Baylor University Baylor University School of Law University of Houston University of Houston Law Center University of Houston University of Houston Law Center Texas Houston Bar Association, Member (Health Law Section, Chair 2021-2022; Campaign for the Homeless Committee, Former Member; Law Week Committee, Former Member) Federal Bar Association, Member State Bar of Texas, Member Texas Bar Foundation, Fellow Defense Research Institute, Member Greater Houston Society for Healthcare Risk Management Law Clerk, Hon. David Hittner, Texas Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit. Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client. Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client. Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client. Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case. Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government. Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees. Advised hospital systems regarding affiliation agreements and other complex transactions. Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions. Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas. Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations. Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country. Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases. Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system. Represented a Louisiana hospital system in federal antitrust case. Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client. Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.","searchable_name":"Sara Brinkmann","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427549,"version":1,"owner_type":"Person","owner_id":613,"payload":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","slug":"christopher-burris","email":"cburris@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":24}]},"expertise":[{"id":107,"guid":"107.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":8,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Burris","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4195}]},"capability_group_id":2},"created_at":"2025-05-26T05:02:00.000Z","updated_at":"2025-05-26T05:02:00.000Z","searchable_text":"Burris{{ FIELD }}Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.{{ FIELD }}Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.{{ FIELD }}Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed.{{ FIELD }}Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation.{{ FIELD }}Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.{{ FIELD }}Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs.{{ FIELD }}Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.{{ FIELD }}Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues.{{ FIELD }}Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.{{ FIELD }}Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.{{ FIELD }}Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.{{ FIELD }}Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information.{{ FIELD }}Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.{{ FIELD }}Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.{{ FIELD }}Chris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.\nAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/qui tam matters, handling dozens of cases concerning a variety of issues.\nIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\nPreviously, Chris served on active duty in the U.S. Navy Judge Advocate General’s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law. Christopher C Burris Partner Vanderbilt University Vanderbilt University School of Law University of North Carolina at Chapel Hill University of North Carolina School of Law Georgetown University Georgetown University Law Center Supreme Court of the United States U.S. District Court for the Western District of North Carolina Georgia North Carolina Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme. Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations. Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed. Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation. Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs. Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs. Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program. Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues. Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs. Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government. Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company. Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information. Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes. Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.","searchable_name":"Christopher C. Burris (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":426829,"version":1,"owner_type":"Person","owner_id":5863,"payload":{"bio":"\u003cp\u003eChristine M. Carletta is a\u0026nbsp;partner in the Washington, D.C. office of King \u0026amp; Spalding. As\u0026nbsp;a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients\u0026rsquo; objectives through all phases of litigation and appeal. Christine\u0026rsquo;s extensive experience covers a broad range of subjects including\u0026nbsp;Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and\u0026nbsp;class actions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of\u0026nbsp;the Vanderbilt Journal of Entertainment and Technology Law.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"christine-carletta","email":"ccarletta@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":3,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":8,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":11,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Carletta","nick_name":"Christine","clerkships":[{"name":"Law Clerk, The Honorable Chad A. Readler, U.S. Court of Appeals for the Sixth Circuit","years_held":"2019 - 2020"},{"name":"Law Clerk, The Honorable James C. Mahan, U.S. District Court for the District of Nevada","years_held":"2015 - 2016"}],"first_name":"Christine","title_rank":9999,"updated_by":32,"law_schools":[{"id":2442,"meta":{"degree":"Juris Doctor","honors":"","is_law_school":"1","graduation_date":"2015-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChristine M. Carletta is a\u0026nbsp;partner in the Washington, D.C. office of King \u0026amp; Spalding. As\u0026nbsp;a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients\u0026rsquo; objectives through all phases of litigation and appeal. Christine\u0026rsquo;s extensive experience covers a broad range of subjects including\u0026nbsp;Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and\u0026nbsp;class actions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of\u0026nbsp;the Vanderbilt Journal of Entertainment and Technology Law.\u0026nbsp;\u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9711}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:14.000Z","updated_at":"2025-05-26T04:57:14.000Z","searchable_text":"Carletta{{ FIELD }}Christine M. Carletta is a partner in the Washington, D.C. office of King \u0026amp; Spalding. As a member of the firm’s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients’ objectives through all phases of litigation and appeal. Christine’s extensive experience covers a broad range of subjects including Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and class actions. \nPrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of the Vanderbilt Journal of Entertainment and Technology Law.   Partner Bowdoin College  Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Tenth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Northern District of Illinois District of Columbia New York Law Clerk, The Honorable Chad A. Readler, U.S. Court of Appeals for the Sixth Circuit Law Clerk, The Honorable James C. Mahan, U.S. District Court for the District of Nevada","searchable_name":"Christine Carletta","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":446321,"version":1,"owner_type":"Person","owner_id":5906,"payload":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","slug":"craig-carpenito","email":"ccarpenito@kslaw.com","phone":"","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":8,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":9,"source":"smartTags"},{"id":120,"guid":"120.capabilities","index":10,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":11,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":12,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":13,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":14,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":15,"source":"capabilities"},{"id":803,"guid":"803.smart_tags","index":16,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":17,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":18,"source":"smartTags"}],"is_active":true,"last_name":"Carpenito","nick_name":"Craig","clerkships":[],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":1790,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2000-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}],"linked_in_url":"https://www.linkedin.com/in/craig-carpenito-a3269612/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8527}]},"capability_group_id":2},"created_at":"2026-03-02T21:59:43.000Z","updated_at":"2026-03-02T21:59:43.000Z","searchable_text":"Carpenito{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described as \\\"an outstanding attorney and seasoned white-collar adviser\\\" that is “extremely dedicated to his clients”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"\\\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described by a healthcare client as having \\\"deep subject matter knowledge.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading financial services lawyer \\\"with extensive governmental and regulatory expertise.\\\"\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in white-collar defense and government/internal investigations\", :detail=\u0026gt;\"Law360, 2012\"}{{ FIELD }}{:title=\u0026gt;\"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018\", :detail=\u0026gt;\"Super Lawyers\"}{{ FIELD }}Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.{{ FIELD }}Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.{{ FIELD }}Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.{{ FIELD }}Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.{{ FIELD }}Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.{{ FIELD }}Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.{{ FIELD }}Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.{{ FIELD }}Former U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding’s Special Matters \u0026amp; Government Investigations practice. Craig’s experience heading one of the nation’s largest U.S. Attorney’s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients’ most complex and sensitive problems.  Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.\nImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.  As U.S. Attorney, Craig made significant organizational changes, including creating the nation’s first standalone opioid enforcement unit and the District’s first cybercrimes unit.  Craig also expanded the  number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.   In August 2018, working with DOJ’s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey. \nDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ’s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.  In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.  Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ’s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.  He was a member of the Attorney General’s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\nPrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm’s litigation and trial practice group and also led its white collar, government and internal investigations team.  Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC’s Office of International Affairs and the UK’s Financial Conduct Authority and Serious Fraud Office.  Craig also represented clients in complex civil litigations and trials in federal and state courts.\nEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.  Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission’s Division of Enforcement.\nRecent Publication:Co-authored a chapter in PLI’s SEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations Partner Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare Chambers USA Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients” Chambers USA \"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\" Chambers USA Described by a healthcare client as having \"deep subject matter knowledge.\" Chambers USA Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\" Legal 500 Named a Rising Star in white-collar defense and government/internal investigations Law360, 2012 Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018 Super Lawyers Rider University  Seton Hall University Seton Hall University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Western District of New York U.S. District Court for the District of New Jersey New Jersey New York American Bar Association National Association of Former United States Attorneys (NAFUSA) The New York Council of Defense Lawyers (NYCDL) The Association of Criminal Defense Lawyers of New Jersey New Jersey Reentry Corporation Training Center Board of Trustees New York State Bar Association New Jersey State Bar Association Association of the Federal Bar of New Jersey (Advisory Committee Member) SIFMA, Legal and Compliance Division Association of Securities and Exchange Commission Alumni The United States Attorney’s Office for the District of New Jersey Alumni Association United States District Court for the District of New Jersey Lawyer’s Advisory Committee Seton Hall University School of Law Board of Visitors Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations. Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices. Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice. Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix. Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client. Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices. Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations. Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC. Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets. Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.","searchable_name":"Craig Carpenito","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null}]}}